These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

310 related items for PubMed ID: 16739307

  • 1. Single-institute phase I/II trial of alternating chemoradiotherapy with 5-FU and nedaplatin for esophageal carcinoma.
    Kodaira T, Fuwa N, Kamata M, Furutani K, Tachibana H, Yamazaki T.
    Anticancer Res; 2006; 26(1B):471-8. PubMed ID: 16739307
    [Abstract] [Full Text] [Related]

  • 2. A phase I/II study of nedaplatin and 5-fluorouracil with concurrent radiotherapy in patients with esophageal cancer.
    Sato Y, Takayama T, Sagawa T, Okamoto T, Miyanishi K, Sato T, Araki H, Iyama S, Abe S, Murase K, Takimoto R, Nagakura H, Hareyama M, Kato J, Niitsu Y.
    Cancer Chemother Pharmacol; 2006 Nov; 58(5):570-6. PubMed ID: 16463059
    [Abstract] [Full Text] [Related]

  • 3. [Phase I study of the combination of nedaplatin (NED), adriamycin (ADM), and 5-fluorouracil (5-FU) (NAF) for treatment of unresectable advanced esophageal cancer].
    Hirao M, Fujitani K, Tsujinaka T.
    Gan To Kagaku Ryoho; 2005 Jan; 32(1):53-6. PubMed ID: 15675582
    [Abstract] [Full Text] [Related]

  • 4. Combined-modality therapy for esophageal cancer: phase I trial of escalating doses of paclitaxel in combination with cisplatin, 5-fluorouracil, and high-dose radiation before esophagectomy.
    Weiner LM, Colarusso P, Goldberg M, Dresler C, Coia LR.
    Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-93-S19-95. PubMed ID: 9427276
    [Abstract] [Full Text] [Related]

  • 5. Prospective study of alternating chemoradiotherapy consisting of extended-field dynamic conformational radiotherapy and systemic chemotherapy using 5-FU and nedaplatin for patients in high-risk group with cervical carcinoma.
    Kodaira T, Fuwa N, Nakanishi T, Tachibana H, Nakamura T, Tomita N, Nakahara R, Inokuchi H.
    Int J Radiat Oncol Biol Phys; 2009 Jan 01; 73(1):251-8. PubMed ID: 18513885
    [Abstract] [Full Text] [Related]

  • 6. Twice-daily radiotherapy as concurrent boost technique during two chemotherapy cycles in neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: mature results of phase II study.
    Choi N, Park SD, Lynch T, Wright C, Ancukiewicz M, Wain J, Donahue D, Mathisen D.
    Int J Radiat Oncol Biol Phys; 2004 Sep 01; 60(1):111-22. PubMed ID: 15337546
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and toxicity of nedaplatin and 5-FU with radiation treatment for advanced esophageal carcinomas.
    Kato H, Fukuchi M, Manda R, Nakajima M, Miyazaki T, Sohda M, Masuda N, Fukai Y, Tsukada K, Kuwano H.
    Anticancer Res; 2003 Sep 01; 23(4):3493-8. PubMed ID: 12926096
    [Abstract] [Full Text] [Related]

  • 8. Phase II study of cisplatin and 5-fluorouracil with concurrent radiotherapy in advanced squamous cell carcinoma of the esophagus: a Japan Esophageal Oncology Group (JEOG)/Japan Clinical Oncology Group trial (JCOG9516).
    Ishida K, Ando N, Yamamoto S, Ide H, Shinoda M.
    Jpn J Clin Oncol; 2004 Oct 01; 34(10):615-9. PubMed ID: 15591460
    [Abstract] [Full Text] [Related]

  • 9. A phase II study of weekly methotrexate, cisplatin, and 24-hour infusion of high-dose 5-fluorouracil and leucovorin (MP-HDFL) in patients with metastatic and recurrent esophageal cancer-improving toxicity profile by infusional schedule and double biochemical modulation of 5-fluorouracil.
    Hsu CH, Cheng AL, Hsu C, Yang CH, Lu YS, Lin CC, Bu CF, Yeh KH.
    Anticancer Res; 2002 Oct 01; 22(6B):3621-7. PubMed ID: 12552966
    [Abstract] [Full Text] [Related]

  • 10. [Concurrent chemoradiotherapy with nedaplatin and 5-fluorouracil (5-fu) for locally advanced squamous cell carcinoma of the esophagus].
    Kubo N, Morimoto J, Tanaka H, Ohira M, Noda E, Amano R, Inoue T, Yamada N, Yashiro M, Maeda K, Yamashita Y, Muguruma K, Sawada T, Hirakawa K.
    Gan To Kagaku Ryoho; 2009 Nov 01; 36(12):1997-9. PubMed ID: 20037303
    [Abstract] [Full Text] [Related]

  • 11. [Phase II clinical trial of home-produced Nedaplatin in treating advanced esophageal carcinoma].
    Xu RH, Shi YX, Guan ZZ, Jiang WQ, Huang H, Ma ZY, Wang JH, Hu XH, Xie WM, Li XG, Liu YL, Pan LX, Dai AD, Zhuang W, Zhang C.
    Ai Zheng; 2006 Dec 01; 25(12):1565-8. PubMed ID: 17166388
    [Abstract] [Full Text] [Related]

  • 12. Weekly high-dose 5-fluorouracil as a 24-h infusion and sodium folinic acid (AIO regimen) plus irinotecan in patients with locally advanced nonresectable and metastatic adenocarcinoma or squamous cell carcinoma of the oesophagus: a phase II trial.
    Wolff K, Wein A, Reulbach U, Männlein G, Brückl V, Meier C, Ostermeier N, Schwab SA, Horbach T, Hohenberger W, Hahn EG, Boxberger F.
    Anticancer Drugs; 2009 Mar 01; 20(3):165-73. PubMed ID: 19125117
    [Abstract] [Full Text] [Related]

  • 13. Preoperative combined modality therapy with paclitaxel, carboplatin, prolonged infusion 5-fluorouracil, and radiation therapy in localized esophageal cancer: preliminary results of a Minnie Pearl Cancer Research Network phase II trial.
    Meluch AA, Hainsworth JD, Gray JR, Thomas M, Whitworth PL, Davis JL, Greco FA.
    Cancer J Sci Am; 1999 Mar 01; 5(2):84-91. PubMed ID: 10198730
    [Abstract] [Full Text] [Related]

  • 14. Selective dose escalation of chemoradiotherapy for esophageal cancer: role of treatment intensification.
    Seung SK, Smith JW, Molendyk J, Bader SB, Phillips M, Regan J, Louie J, Soo E, Seligman M, Ruzich J, Skokan L, Ross HJ.
    Semin Oncol; 2004 Dec 01; 31(6 Suppl 18):13-9. PubMed ID: 15726517
    [Abstract] [Full Text] [Related]

  • 15. Paclitaxel, 5-fluorouracil, hydroxyurea, and concomitant radiation therapy for poor-prognosis head and neck cancer.
    Vokes EE, Haraf DJ, Brockstein BE, Weichselbaum RR.
    Semin Radiat Oncol; 1999 Apr 01; 9(2 Suppl 1):70-6. PubMed ID: 10210543
    [Abstract] [Full Text] [Related]

  • 16. [Nedaplatin and 5-fluorouracil combined with radiotherapy for advanced esophageal cancer].
    Nakamura T, Ide H, Eguchi R, Hayashi K, Ota M, Narumiya K, Takasaki K, Mitsuhashi M.
    Gan To Kagaku Ryoho; 2003 Jun 01; 30(6):803-7. PubMed ID: 12852347
    [Abstract] [Full Text] [Related]

  • 17. Long-term toxicity after definitive chemoradiotherapy for squamous cell carcinoma of the thoracic esophagus.
    Ishikura S, Nihei K, Ohtsu A, Boku N, Hironaka S, Mera K, Muto M, Ogino T, Yoshida S.
    J Clin Oncol; 2003 Jul 15; 21(14):2697-702. PubMed ID: 12860946
    [Abstract] [Full Text] [Related]

  • 18. [Nedaplatin (NDP)-combination therapy (NDP/5-FU,NDP/S-1) for oral cancer].
    Maruoka Y, Ando T, Ogiuchi Y, Ogiuchi H.
    Gan To Kagaku Ryoho; 2007 May 15; 34(5):713-7. PubMed ID: 17496443
    [Abstract] [Full Text] [Related]

  • 19. [A case of esophageal carcinoma with multiple liver metastases successfully treated with nedaplatin (NDP) and 5-fluorouracil (5-FU) combined with radiotherapy].
    Kaneko K, Ito H, Ito T, Konishi K, Kurahashi T, Yamamoto T, Eguchi J, Kitahara T, Mitamura K.
    Gan To Kagaku Ryoho; 2001 Jun 15; 28(6):831-4. PubMed ID: 11432353
    [Abstract] [Full Text] [Related]

  • 20. [A case of advanced esophageal cancer with multiple lymph node metastases successfully treated with induction chemotherapy consisting of nedaplatin and 5-FU followed by chemoradiotherapy].
    Sasaki T, Nakamura K, Toba T, Kimura M, Ohga S, Urashima Y, Terashima H, Masuda K.
    Gan To Kagaku Ryoho; 2002 Aug 15; 29(8):1417-20. PubMed ID: 12214470
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.